SEARCH Ends Badly For Simvastatin 80 Mg; FDA Restricts Use To Existing Patients

New clinical trial data and adverse event reports show high-dose simvastatin-containing products have a greater risk for muscle toxicity than other statins, the agency concludes.

More from Archive

More from Pink Sheet